Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-87.47M
↓ 91% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-45.68M
Historical baseline
PeriodValueYoY Change
2025$-87.47M-34.9%
2024$-64.83M-138.5%
2023$-27.18M-738.4%
2022$-3.24M-